HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea
· Delayed Price · Currency is KRW 6,360.00
-125.00 (-1.93%)
At close: Apr 23, 2026
HLB bioStep Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 74,050 | 58,169 | 52,814 | 86,277 | 64,403 | Upgrade
|
| Other Revenue | - | - | - | - | 0 | Upgrade
|
| Revenue | 74,050 | 58,169 | 52,814 | 86,277 | 64,403 | Upgrade
|
| Revenue Growth (YoY) | 27.30% | 10.14% | -38.78% | 33.96% | 10.05% | Upgrade
|
| Cost of Revenue | 18,143 | 17,339 | 17,533 | 32,343 | 23,147 | Upgrade
|
| Gross Profit | 55,907 | 40,830 | 35,281 | 53,934 | 41,256 | Upgrade
|
| Selling, General & Admin | 57,709 | 46,407 | 31,623 | 40,986 | 26,527 | Upgrade
|
| Research & Development | 936.39 | 824.35 | 811.99 | 978.14 | 1,165 | Upgrade
|
| Amortization of Goodwill & Intangibles | 692.1 | 492.52 | 63.28 | 70.28 | 30 | Upgrade
|
| Other Operating Expenses | 889.67 | 858.76 | 712.99 | 709.09 | 696.32 | Upgrade
|
| Operating Expenses | 64,546 | 53,877 | 36,467 | 48,625 | 32,249 | Upgrade
|
| Operating Income | -8,639 | -13,048 | -1,186 | 5,309 | 9,007 | Upgrade
|
| Interest Expense | -2,051 | -858.96 | -3,471 | -4,246 | -184.7 | Upgrade
|
| Interest & Investment Income | 817.3 | 1,821 | 1,469 | 1,401 | 85 | Upgrade
|
| Earnings From Equity Investments | -4,460 | 1.68 | -488.74 | -1,659 | 3,608 | Upgrade
|
| Currency Exchange Gain (Loss) | -10.3 | 4.16 | 32.3 | 13.81 | 9.9 | Upgrade
|
| Other Non Operating Income (Expenses) | 33.86 | 233.81 | 561.71 | -2,767 | 775.48 | Upgrade
|
| EBT Excluding Unusual Items | -14,309 | -11,845 | -3,083 | -1,947 | 13,300 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,714 | 182.73 | 3,418 | 534.22 | -440.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | 16.35 | 135.08 | -9.47 | -23.37 | -33.11 | Upgrade
|
| Asset Writedown | -4,948 | - | - | -907.99 | - | Upgrade
|
| Pretax Income | -17,527 | -11,528 | 325.66 | -2,345 | 12,827 | Upgrade
|
| Income Tax Expense | 2,728 | -1,835 | 379.9 | -1,462 | 1,295 | Upgrade
|
| Earnings From Continuing Operations | -20,255 | -9,693 | -54.24 | -882.73 | 11,532 | Upgrade
|
| Net Income to Company | -20,255 | -9,693 | -54.24 | -882.73 | 11,532 | Upgrade
|
| Minority Interest in Earnings | 1,293 | 1,128 | -109.81 | -125.27 | -501.4 | Upgrade
|
| Net Income | -18,962 | -8,564 | -164.04 | -1,008 | 11,031 | Upgrade
|
| Net Income to Common | -18,962 | -8,564 | -164.04 | -1,008 | 11,031 | Upgrade
|
| Net Income Growth | - | - | - | - | 32.87% | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 15 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 15 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | 0.82% | 9.45% | 9.59% | 0.02% | 1.35% | Upgrade
|
| EPS (Basic) | -1120.00 | -510.00 | -10.69 | -72.00 | 809.35 | Upgrade
|
| EPS (Diluted) | -1120.00 | -510.00 | -10.69 | -72.00 | 790.00 | Upgrade
|
| EPS Growth | - | - | - | - | 31.42% | Upgrade
|
| Free Cash Flow | 1,113 | -20,594 | 1,189 | 1,587 | -11,135 | Upgrade
|
| Free Cash Flow Per Share | 65.75 | -1226.35 | 77.53 | 113.33 | -795.47 | Upgrade
|
| Gross Margin | 75.50% | 70.19% | 66.80% | 62.51% | 64.06% | Upgrade
|
| Operating Margin | -11.67% | -22.43% | -2.25% | 6.15% | 13.98% | Upgrade
|
| Profit Margin | -25.61% | -14.72% | -0.31% | -1.17% | 17.13% | Upgrade
|
| Free Cash Flow Margin | 1.50% | -35.40% | 2.25% | 1.84% | -17.29% | Upgrade
|
| EBITDA | -3,908 | -8,345 | 2,290 | 9,412 | 12,033 | Upgrade
|
| EBITDA Margin | -5.28% | -14.35% | 4.33% | 10.91% | 18.68% | Upgrade
|
| D&A For EBITDA | 4,731 | 4,703 | 3,476 | 4,103 | 3,026 | Upgrade
|
| EBIT | -8,639 | -13,048 | -1,186 | 5,309 | 9,007 | Upgrade
|
| EBIT Margin | -11.67% | -22.43% | -2.25% | 6.15% | 13.98% | Upgrade
|
| Effective Tax Rate | - | - | 116.66% | - | 10.09% | Upgrade
|
| Advertising Expenses | 91.38 | 178.58 | 152.13 | 340.63 | 256.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.